NO944909L - Fremgangsmåter for inhibering av mannlig infertilitet - Google Patents

Fremgangsmåter for inhibering av mannlig infertilitet

Info

Publication number
NO944909L
NO944909L NO944909A NO944909A NO944909L NO 944909 L NO944909 L NO 944909L NO 944909 A NO944909 A NO 944909A NO 944909 A NO944909 A NO 944909A NO 944909 L NO944909 L NO 944909L
Authority
NO
Norway
Prior art keywords
male infertility
methods
inhibiting male
inhibiting
hexamethyleneamino
Prior art date
Application number
NO944909A
Other languages
English (en)
Other versions
NO944909D0 (no
Inventor
Jeffrey Alan Dodge
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO944909D0 publication Critical patent/NO944909D0/no
Publication of NO944909L publication Critical patent/NO944909L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Det er beskrevet en fremgangsmåte for Inhibering av mannlig Infertilitet Innbefattende administrering til et menneske som har behov for dette av en effektiv mengde av en forbindelse som har formelen OCH2CH2¿ R2 (D hvori R1 og R3 uavhengig av hverandre er hydrogen, -CH3. O O (, alkyl), eller -C-Ar, hvor Ar er eventuelt substituert f enyl ; R2 er valgt fra gruppen bestående av pyrrolldln, heksametylenamlno og piper Idlno; eller et farmasøytisk akseptabelt salt eller solvat derav.
NO944909A 1993-12-21 1994-12-19 Fremgangsmåter for inhibering av mannlig infertilitet NO944909L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/168,482 US5596004A (en) 1993-12-21 1993-12-21 Methods of inhibiting male infertility

Publications (2)

Publication Number Publication Date
NO944909D0 NO944909D0 (no) 1994-12-19
NO944909L true NO944909L (no) 1995-06-22

Family

ID=22611664

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944909A NO944909L (no) 1993-12-21 1994-12-19 Fremgangsmåter for inhibering av mannlig infertilitet

Country Status (14)

Country Link
US (1) US5596004A (no)
EP (1) EP0659424A1 (no)
JP (1) JPH07215866A (no)
KR (1) KR950016736A (no)
CN (1) CN1108101A (no)
AU (1) AU8155594A (no)
CA (1) CA2138506A1 (no)
CZ (1) CZ321994A3 (no)
HU (1) HUT71341A (no)
IL (1) IL112052A0 (no)
NO (1) NO944909L (no)
NZ (1) NZ270174A (no)
RU (1) RU94044487A (no)
ZA (1) ZA9410087B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW442286B (en) * 1996-02-28 2001-06-23 Pfizer New therapeutic uses of estrogen agonists
IL120266A (en) 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
EP1113007A1 (en) 1999-12-24 2001-07-04 Pfizer Inc. Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
JP2015506988A (ja) * 2012-02-14 2015-03-05 レプロス セラピューティクス インコーポレイティド 半減期の短い選択的エストロゲン受容体モジュレーターおよびその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体

Also Published As

Publication number Publication date
CZ321994A3 (en) 1995-09-13
AU8155594A (en) 1995-06-29
RU94044487A (ru) 1996-10-20
NO944909D0 (no) 1994-12-19
HUT71341A (en) 1995-11-28
CA2138506A1 (en) 1995-06-22
NZ270174A (en) 1996-08-27
EP0659424A1 (en) 1995-06-28
US5596004A (en) 1997-01-21
KR950016736A (ko) 1995-07-20
JPH07215866A (ja) 1995-08-15
ZA9410087B (en) 1996-06-19
HU9403670D0 (en) 1995-02-28
IL112052A0 (en) 1995-03-15
CN1108101A (zh) 1995-09-13

Similar Documents

Publication Publication Date Title
NO944927L (no) Fremgangsmåte for inhibering av pulmonar hypertensiv sykdom
NO973635L (no) Fremgangsmåte for hemming av celle-celle adhesjon
NO944914L (no) Fremgangsmåte for å inhibere autoimmunsykdommer
NO944919L (no) Fremgangsmåte for å inhibere atrofi av huden eller vagina
NO944928L (no) Fremgangsmåter for inhibering av Alzheimers sykdom
DK0652005T3 (da) Fremgangsmåder til inhibering af endometriose
NO944930L (no) Hemming av dysfunksjonell uterin blödning
DK0651999T3 (da) Fremgangsmåder til inhibering af livmoderfibrose
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
NO944926L (no) Fremgangsmåter for å inhibere myeloperoksidaseaktivitet
NO944934L (no) Hemming av vasomotoriske symptomer og tilhörende psykologiske forstyrrelser i forbindelse med post-menopausalt syndrom
MX9701360A (es) Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion.
NO944924L (no) Fremgangsmåter for inhibering av Turner's syndrom
NO944933L (no) Fremgangsmåte for å inhibere sykdomstilstander i brystet
DK0662325T3 (da) Inhibering af ovariedysgenese, forsinket pubertet eller sexuel infantilisme
NO944931L (no) Anvendelse av 2-fenyl-3-aroylbenzotiofener for inhibering av tidlig seksuell modenhet
NO975580L (no) Fremgangsmåte for å inhibere melanom
NO944923L (no) Hemming av vektökning eller indusering av vekttap
NO970786L (no) Fremgangsmåte for hemming av benprotesedegradering
NO973367L (no) Fremgangsmåte for å inhibere miljömessige östrogen
NO944909L (no) Fremgangsmåter for inhibering av mannlig infertilitet
NO981578L (no) FremgangsmÕte for hemming av plasminogenaktivatorhemmer I
NO973609L (no) Fremgangsmåte for å inhibere effektene av IL-6
NO944577L (no) Hemming av effekten av amyloidogene proteiner
NO971029L (no) Fremgangsmåter for hemming av endometriale metoser